Venoruton作为放射性保护剂:血液学评估。

Radiobiologia, radiotherapia Pub Date : 1990-01-01

K C Kanwar, V K Shukla, A Verma

{"title":"Venoruton作为放射性保护剂:血液学评估。","authors":"K C Kanwar, V K Shukla, A Verma","doi":"","DOIUrl":null,"url":null,"abstract":"Efficacy of Venoruton--O-(hydroxyethyl) Rutoside--as a radioprotector has been tested on haematological profile of rats which were subjected to whole body radiation (500 rads). The results show radiation induced lesions in respect of total (TLC) and differential leukocyte counts (DLC)/and haemoglobin are significantly lessened when Venoruton was administered prior to radiation exposure.","PeriodicalId":76404,"journal":{"name":"Radiobiologia, radiotherapia","volume":"31 6","pages":"517-22"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Venoruton as a radioprotector: a haematological assessment.\",\"authors\":\"K C Kanwar, V K Shukla, A Verma\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Efficacy of Venoruton--O-(hydroxyethyl) Rutoside--as a radioprotector has been tested on haematological profile of rats which were subjected to whole body radiation (500 rads). The results show radiation induced lesions in respect of total (TLC) and differential leukocyte counts (DLC)/and haemoglobin are significantly lessened when Venoruton was administered prior to radiation exposure.\",\"PeriodicalId\":76404,\"journal\":{\"name\":\"Radiobiologia, radiotherapia\",\"volume\":\"31 6\",\"pages\":\"517-22\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiobiologia, radiotherapia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiobiologia, radiotherapia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在接受全身辐射(500拉德)的大鼠血液学特征上测试了Venoruton- O-(羟乙基)Rutoside作为放射性保护剂的功效。结果显示，在辐射暴露前使用Venoruton时，辐射引起的病变在总(TLC)和差异白细胞计数(DLC)/和血红蛋白方面显着减少。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Venoruton as a radioprotector: a haematological assessment.

Efficacy of Venoruton--O-(hydroxyethyl) Rutoside--as a radioprotector has been tested on haematological profile of rats which were subjected to whole body radiation (500 rads). The results show radiation induced lesions in respect of total (TLC) and differential leukocyte counts (DLC)/and haemoglobin are significantly lessened when Venoruton was administered prior to radiation exposure.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Radiobiologia, radiotherapia

自引率

0.00%

发文量